I think we are a share that only moves upward on new news. Start of trials, trial results, approvals, licence agreements. Until something like that coming along I don’t see us having a significant upward movement. Sale results of Daybue has to be extraordinary good to cause a movement. But we will drift down in the quiet times from lack of interest or increasing short positions. I’d be in favour of repeating the buy back as we all seem to view this share is undervalued at current prices compared with future potential. It doesn’t have to be spent but if it is NEU soaks up more shares at this level or below. In anticipation of the news to start coming through in the future.
NEU Price at posting:
$12.63 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)